US Stock MarketDetailed Quotes

QLGN Qualigen Therapeutics

Watchlist

0.1646
+0.0019+1.17%

Close Sep 13 16:00 ET

0.1601
-0.0045-2.73%

Post 19:46 ET

4.45MMarket Cap-95P/E (TTM)

Qualigen Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

39.09%-1.47M

59.65%-783.59K

14.20%-9.09M

7.84%-1.84M

-272.85%-2.89M

38.65%-2.42M

49.97%-1.94M

28.05%-10.6M

31.51%-2M

74.42%-775.69K

Net income from continuing operations

58.26%-1.48M

37.16%-2.03M

10.22%-12.48M

31.44%-2.47M

-75.05%-3.24M

14.30%-3.54M

25.11%-3.24M

22.36%-13.89M

14.69%-3.6M

39.16%-1.85M

Operating gains losses

81.06%-83.39K

112.11%125.74K

-64.50%-1.38M

-113.32%-24.02K

138.24%122.86K

-2,874.96%-440.29K

-52.02%-1.04M

81.04%-838.98K

243.68%180.37K

81.79%-321.3K

Depreciation and amortization

----

-63.05%4.5K

47.72%4.5K

----

-96.40%12.17K

-96.59%3.04K

-295.01%-166.94K

Other non cash items

-187.74%-223.02K

-71.32%461.93K

--2.55M

--222.44K

--459.68K

--254.18K

--1.61M

----

Change In working capital

-58.81%275.34K

28.51%602.85K

272.91%1.11M

-52.84%356.09K

-743.66%-382.08K

150.98%668.47K

421.44%469.1K

-129.05%-642.87K

150.08%755.03K

-78.59%59.36K

-Change in prepaid assets

558.37%44.27K

303.98%721.45K

-108.48%-264.74K

49.24%375.36K

-585.57%-825.41K

100.81%6.72K

-36.69%178.58K

-109.78%-126.99K

13.49%251.51K

-48.58%169.99K

-Change in payables and accrued expense

-65.08%231.07K

-140.83%-118.61K

366.79%1.38M

-103.83%-19.28K

302.33%443.34K

243.56%661.75K

185.61%290.52K

-136.01%-515.88K

1,897.76%503.52K

-438,122.00%-219.11K

Cash from discontinued investing activities

54.29%-1.21M

-1,481.50%-3.83M

3.82M

-507.53K

-692.31K

-2.65M

-242.35K

Operating cash flow

49.65%-1.47M

70.25%-783.59K

22.22%-10.3M

-153.45%-5.67M

129.22%929.74K

25.79%-2.93M

32.14%-2.63M

10.07%-13.25M

23.19%-2.24M

-4.94%-3.18M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Investing cash flow

823.01%350K

--0

2,394.23%4.22M

196.33%235.4K

37,642.93%4.23M

-139.84%-48.41K

-299.01%-198.01K

-29.99%-183.76K

-1,336.82%-244.38K

-16.49%-11.26K

Financing cash flow

Cash flow from continuing financing activities

1.15M

475K

-118.90%-550K

-103.79%-110K

-13,377.01%-440K

-65.49%2.91M

-64.37%2.9M

-97.44%3.31K

Net issuance payments of debt

--1M

--475K

-118.94%-550K

-103.79%-110K

---440K

--0

2,193.03%2.9M

--2.9M

----

Net common stock issuance

----

--0

----

-100.01%-505

----

Proceeds from stock option exercised by employees

----

--0

----

-98.44%7.17K

--0

-97.44%3.31K

Cash from discontinued financing activities

Financing cash flow

--1.15M

--475K

-118.90%-550K

-103.79%-110K

-13,377.01%-440K

--0

-65.49%2.91M

-64.37%2.9M

-97.44%3.31K

Net cash flow

Beginning cash position

-93.92%93.22K

-94.29%401.8K

-59.86%7.04M

-68.69%2.07M

-93.94%590.64K

-88.73%1.53M

-59.86%7.04M

-26.85%17.54M

-46.23%6.62M

-35.98%9.75M

Current changes in cash

100.86%25.47K

89.10%-308.59K

36.90%-6.64M

-1,416.63%-5.55M

247.86%4.72M

22.17%-2.98M

27.89%-2.83M

-63.41%-10.52M

-91.93%421.24K

-9.52%-3.19M

Effect of exchange rate changes

--0

-287.53%-115.8K

-30.06%-44.52K

--160.32K

--22.64K

---4.88K

--61.75K

End cash Position

-79.91%118.69K

-93.92%93.22K

-87.31%401.8K

-68.69%2.07M

-93.94%590.64K

-88.73%1.53M

-81.95%3.17M

-46.23%6.62M

Free cash flow

49.65%-1.47M

70.25%-783.59K

22.22%-10.3M

-153.45%-5.67M

129.81%929.74K

26.05%-2.93M

33.00%-2.63M

10.92%-13.25M

23.64%-2.24M

-2.52%-3.12M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	39.09%-1.47M	59.65%-783.59K	14.20%-9.09M	7.84%-1.84M	-272.85%-2.89M	38.65%-2.42M	49.97%-1.94M	28.05%-10.6M	31.51%-2M	74.42%-775.69K
Net income from continuing operations	58.26%-1.48M	37.16%-2.03M	10.22%-12.48M	31.44%-2.47M	-75.05%-3.24M	14.30%-3.54M	25.11%-3.24M	22.36%-13.89M	14.69%-3.6M	39.16%-1.85M
Operating gains losses	81.06%-83.39K	112.11%125.74K	-64.50%-1.38M	-113.32%-24.02K	138.24%122.86K	-2,874.96%-440.29K	-52.02%-1.04M	81.04%-838.98K	243.68%180.37K	81.79%-321.3K
Depreciation and amortization	----	----	-63.05%4.5K	47.72%4.5K	----	----	----	-96.40%12.17K	-96.59%3.04K	-295.01%-166.94K
Other non cash items	-187.74%-223.02K	-71.32%461.93K	--2.55M	--222.44K	--459.68K	--254.18K	--1.61M	----	----	----
Change In working capital	-58.81%275.34K	28.51%602.85K	272.91%1.11M	-52.84%356.09K	-743.66%-382.08K	150.98%668.47K	421.44%469.1K	-129.05%-642.87K	150.08%755.03K	-78.59%59.36K
-Change in prepaid assets	558.37%44.27K	303.98%721.45K	-108.48%-264.74K	49.24%375.36K	-585.57%-825.41K	100.81%6.72K	-36.69%178.58K	-109.78%-126.99K	13.49%251.51K	-48.58%169.99K
-Change in payables and accrued expense	-65.08%231.07K	-140.83%-118.61K	366.79%1.38M	-103.83%-19.28K	302.33%443.34K	243.56%661.75K	185.61%290.52K	-136.01%-515.88K	1,897.76%503.52K	-438,122.00%-219.11K
Cash from discontinued investing activities	0	0	54.29%-1.21M	-1,481.50%-3.83M	3.82M	-507.53K	-692.31K	-2.65M	-242.35K
Operating cash flow	49.65%-1.47M	70.25%-783.59K	22.22%-10.3M	-153.45%-5.67M	129.22%929.74K	25.79%-2.93M	32.14%-2.63M	10.07%-13.25M	23.19%-2.24M	-4.94%-3.18M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow	823.01%350K	--0	2,394.23%4.22M	196.33%235.4K	37,642.93%4.23M	-139.84%-48.41K	-299.01%-198.01K	-29.99%-183.76K	-1,336.82%-244.38K	-16.49%-11.26K
Financing cash flow
Cash flow from continuing financing activities	1.15M	475K	-118.90%-550K	-103.79%-110K	-13,377.01%-440K	0	0	-65.49%2.91M	-64.37%2.9M	-97.44%3.31K
Net issuance payments of debt	--1M	--475K	-118.94%-550K	-103.79%-110K	---440K	--0	--0	2,193.03%2.9M	--2.9M	----
Net common stock issuance	----	----	--0	----	----	----	----	-100.01%-505	----	----
Proceeds from stock option exercised by employees	----	----	--0	--0	--0	----	----	-98.44%7.17K	--0	-97.44%3.31K
Cash from discontinued financing activities	0	0	0	0	0	0	0	0	0
Financing cash flow	--1.15M	--475K	-118.90%-550K	-103.79%-110K	-13,377.01%-440K	--0	--0	-65.49%2.91M	-64.37%2.9M	-97.44%3.31K
Net cash flow
Beginning cash position	-93.92%93.22K	-94.29%401.8K	-59.86%7.04M	-68.69%2.07M	-93.94%590.64K	-88.73%1.53M	-59.86%7.04M	-26.85%17.54M	-46.23%6.62M	-35.98%9.75M
Current changes in cash	100.86%25.47K	89.10%-308.59K	36.90%-6.64M	-1,416.63%-5.55M	247.86%4.72M	22.17%-2.98M	27.89%-2.83M	-63.41%-10.52M	-91.93%421.24K	-9.52%-3.19M
Effect of exchange rate changes	--0	--0	--0	--0	-287.53%-115.8K	-30.06%-44.52K	--160.32K	--22.64K	---4.88K	--61.75K
End cash Position	-79.91%118.69K	-93.92%93.22K	-87.31%401.8K	-87.31%401.8K	-68.69%2.07M	-93.94%590.64K	-88.73%1.53M	-81.95%3.17M	-81.95%3.17M	-46.23%6.62M
Free cash flow	49.65%-1.47M	70.25%-783.59K	22.22%-10.3M	-153.45%-5.67M	129.81%929.74K	26.05%-2.93M	33.00%-2.63M	10.92%-13.25M	23.64%-2.24M	-2.52%-3.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data